Beijing Luzhu Biotechnology Co., Ltd.
Quick facts
Phase 3 pipeline
- Recombinant Herpes Zoster Vaccine · Immunology
The recombinant Herpes Zoster Vaccine works by stimulating the body's immune system to produce a specific response against the Herpes Zoster virus.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Beijing Luzhu Biotechnology Co., Ltd. portfolio CI brief
- Beijing Luzhu Biotechnology Co., Ltd. pipeline updates RSS
Frequently asked questions about Beijing Luzhu Biotechnology Co., Ltd.
What is Beijing Luzhu Biotechnology Co., Ltd.'s pipeline?
Beijing Luzhu Biotechnology Co., Ltd. has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Recombinant Herpes Zoster Vaccine.
Related
- Sector hub: All tracked pharma companies